The Pennant Group, Inc. (PNTG) suffered a 5.6% plummet in its stock price on Friday's pre-market trading session, despite meeting analysts' expectations for the fourth quarter of 2024. The healthcare facilities and services provider reported adjusted earnings of $0.24 per share, in line with the consensus estimate of $0.24.

However, the company's revenue growth of 29.4% year-over-year to $188.89 million fell short of market expectations, which were looking for $185.83 million. This lackluster revenue growth, coupled with the stock's recent underperformance, with a 3.7% decline this quarter, appears to have contributed to the selloff.

Despite the plummet, analysts remain optimistic about Pennant Group, with a consensus "buy" rating and a median 12-month price target of $37.00. However, the market's reaction suggests that investors were not entirely satisfied with the company's performance and growth prospects.